Galectin-3 blockade suppresses the growth of cetuximab-resistant human oral squamous cell carcinoma

Oral squamous cell carcinoma (OSCC) is a cancer associated with high mortality (accounting for 3.1/100,000 deaths per year in Brazil in 2013) and a high frequency of amplification in the expression of the epidermal growth factor receptor (EGFR). Treatment with the EGFR inhibitor cetuximab leads to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Peng, Cui, Shuanlong, Liao, Xiangling, Yao, Xiaoguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365594/
https://www.ncbi.nlm.nih.gov/pubmed/34328195
http://dx.doi.org/10.3892/mmr.2021.12325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365594/
https://www.ncbi.nlm.nih.gov/pubmed/34328195
http://dx.doi.org/10.3892/mmr.2021.12325

Ejemplares similares